The clinical relevance of DNL in the development of NAFLD has been demonstrated by studies revealing greater liver fat content in patients with a (rs738409(G)) polymorphism in the Patatin-like phospholipase domain-containing protein 3 (PNPLA3). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.